FindTrial
Sign In

The efficacy of lidocaine medicated plaster and intravenous for neuropathic pain after thoracotomy: a randomized-controlled study

The efficacy of lidocaine medicated plaster and intravenous for neuropathic pain after thoracotomy: a randomized-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060461
Enrollment
Unknown
Registered
2022-06-01
Start date
2022-07-10
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropathic pain after thoracotomy

Interventions

Group 1:Lidocaine is administered through the skin
Group 2:Intravenous infusion of lidocaine

Sponsors

Tongji Hospital Affiliated to Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Patients with chronic post-thoracotomy pain (CPP) diagnosis.

Exclusion criteria

Exclusion criteria: 1. Severe heart disease, severe damage of liver and kidney function; 2. Allergy to lidocaine; 3. Other types of chronic pain; 4. Participated in other analgesic studies in the past month; 5. Patients who have previously received nerve block, radiofrequency regulation and other interventional therapy.

Design outcomes

Primary

MeasureTime frame
Numeric rating scale score for pain;Quantitative sensory testing (QST);—

Secondary

MeasureTime frame
The McGill pain questionnaire overview;Self-rating depression scale;Self-rating anxiety scale;The chronic pain sleep in ventory, CPSI;SF-36 health survey;—

Countries

China

Contacts

Public ContactZhang Xianwei
painfree@qq.com+86 13037154560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026